AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58

Authors: CITRO G DAGNANO I LEONETTI C PERINI R BUCCI B ZON G CALABRETTA B ZUPI G
Citation: G. Citro et al., C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDES ENHANCE THE EFFICACY OF CISPLATIN IN MELANOMA CHEMOTHERAPY IN-VITRO AND IN NUDE-MICE, Cancer research, 58(2), 1998, pp. 283-289

Authors: BAEK SH MEHDI K GUNN J LAMBERT C WILENSKY R CUMBERLAND D VANDERGIESSEN W ZON G LUNNON M MARCH KL
Citation: Sh. Baek et al., ADVENTITIA IS THE PREDOMINANT SITE OF ANTISENSE-C-MYC DELIVERY TO PORCINE CORONARY-ARTERIES BY EACH OF 4 ENDOVASCULAR DELIVERY CATHETERS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7493-7493

Authors: BARSKY D COLVIN ME ZON G GRYAZNOV SM
Citation: D. Barsky et al., HYDRATION EFFECTS ON THE DUPLEX STABILITY OF PHOSPHORAMIDATE DNA-RNA OLIGOMERS, Nucleic acids research, 25(4), 1997, pp. 830-835

Authors: BARSKY D COLVIN ME ZON G GRYAZNOV SM
Citation: D. Barsky et al., HYDRATION EFFECTS ON THE DUPLEX STABILITY OF PHOSPHORAMIDATE DNA-RNA OLIGOMERS, Biophysical journal, 72(2), 1997, p.

Authors: LEONETTI C DAGNANO I LOZUPONE F VALENTINI A GEISER T ZON G CALABRETTA B CITRO G ZUPI G
Citation: C. Leonetti et al., ANTITUMOR EFFECT OF C-MYC ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES ON HUMAN-MELANOMA CELLS IN-VITRO AND IN MICE, Journal of the National Cancer Institute, 88(7), 1996, pp. 419-429

Authors: STULL RA ZON G SZOKA FC
Citation: Ra. Stull et al., AN IN-VITRO MESSENGER-RNA BINDING ASSAY AS A TOOL FOR IDENTIFYING HYBRIDIZATION-COMPETENT ANTISENSE OLIGONUCLEOTIDES, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 6(3), 1996, pp. 221-228

Authors: BISHOP MR IVERSEN PL BAYEVER E SHARP JG GREINER TC COPPLE BL RUDDON R ZON G SPINOLO J ARNESON M ARMITAGE JO KESSINGER A
Citation: Mr. Bishop et al., PHASE-I TRIAL OF AN ANTISENSE OLIGONUCLEOTIDE OL(1)P53 IN HEMATOLOGICMALIGNANCIES, Journal of clinical oncology, 14(4), 1996, pp. 1320-1326

Authors: OFFENSPERGER WB OFFENSPERGER S MORADPOUR D VONWEIZSACKER F WIELAND S HEUSS L ZON G MARION P BLUM HE
Citation: Wb. Offensperger et al., LONG-TERM SUPPRESSION OF DUCK HEPATITIS-B VIRUS-REPLICATION AFTER TREATMENT WITH ANTISENSE OLIGODEOXYNUCLEOTIDES, Hepatology, 24(4), 1996, pp. 371-371

Authors: BRANDA RF MOORE AL HONG R MCCORMACK JJ ZON G CUNNINGHAMRUNDLES C
Citation: Rf. Branda et al., B-CELL PROLIFERATION AND DIFFERENTIATION IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS PRODUCED BY AN ANTISENSE OLIGOMER TO THE REV GENE OF HIV-1, Clinical immunology and immunopathology, 79(2), 1996, pp. 115-121

Authors: BRANDA RF MOORE AL LAFAYETTE AR MATHEWS L HONG R ZON G BROWN T MCCORMACK JJ
Citation: Rf. Branda et al., AMPLIFICATION OF ANTIBODY-PRODUCTION BY PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES, The Journal of laboratory and clinical medicine, 128(3), 1996, pp. 329-338

Authors: DELBUFALO D CUCCO C LEONETTI C CITRO G DAGNANO I BENASSI M GEISER T ZON G CALABRETTA B ZUPI G
Citation: D. Delbufalo et al., EFFECT OF CISPLATIN AND C-MYB ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES COMBINATION ON A HUMAN COLON-CARCINOMA CELL-LINE IN-VITRO AND IN-VIVO, British Journal of Cancer, 74(3), 1996, pp. 387-393

Authors: SKORSKI T NIEBOROWSKASKORSKA M WLODARSKI P ZON G IOZZO RV CALABRETTA B
Citation: T. Skorski et al., ANTISENSE OLIGODEOXYNUCLEOTIDE COMBINATION THERAPY OF PRIMARY CHRONICMYELOGENOUS LEUKEMIA BLAST CRISIS IN SCID MICE, Blood, 88(3), 1996, pp. 1005-1012

Authors: DESERRES M MCNULTY MJ CHRISTENSEN L ZON G FINDLAY JWA
Citation: M. Deserres et al., DEVELOPMENT OF A NOVEL SCINTILLATION PROXIMITY COMPETITIVE HYBRIDIZATION ASSAY FOR THE DETERMINATION OF PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDE PLASMA-CONCENTRATIONS IN A TOXICOKINETIC STUDY, Analytical biochemistry, 233(2), 1996, pp. 228-233

Authors: DESJARDINS J MATA J BROWN T GRAHAM D ZON G IVERSEN P
Citation: J. Desjardins et al., CHOLESTERYL-CONJUGATED PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES MODULATE CYP2B1 EXPRESSION IN-VIVO, Journal of drug targeting., 2(6), 1995, pp. 477-485

Authors: BALENDIRAN K RAO ST SEKHARUDU CY ZON G SUNDARALINGAM M
Citation: K. Balendiran et al., X-RAY STRUCTURES OF THE B-DNA DODECAMER D(CGCGTTAACGCG) WITH AN INVERTED CENTRAL TETRANUCLEOTIDE AND ITS NETROPSIN COMPLEX, Acta crystallographica. Section D, Biological crystallography, 51, 1995, pp. 190-198

Authors: ZON G
Citation: G. Zon, BRIEF OVERVIEW OF CONTROL OF GENETIC EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES AND IN-VIVO APPLICATIONS - PROSPECTS FOR NEUROBIOLOGY, Molecular neurobiology, 10(2-3), 1995, pp. 219-229

Authors: MARKHAM P KAO V FIORELLI V GENDELMAN R ZON G GALLO RC ENSOLI B
Citation: P. Markham et al., ANTISENSE OLIGONUCLEOTIDE TARGETING BASIC FIBROBLAST GROWTH-FACTOR (BFGF) BLOCK GROWTH AND ANGIOGENESIS OF AIDS-KAPOSIS SARCOMA (KS) CELLS AND CYTOKINE-ACTIVATED ENDOTHELIAL-CELLS, AIDS research and human retroviruses, 11, 1995, pp. 96-96

Authors: THOMSON MM HOLLAND M ALHARTHI L ZON G GALLO RC KLOTMAN ME
Citation: Mm. Thomson et al., ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES (S-ODNS) TARGETED TOTHE LEADER SEQUENCE OF HIV-1 RNAS SHOW STRONG INHIBITION OF HIV-1 REPLICATION IN A TRANSIENT TRANSFECTION ASSAY, AIDS research and human retroviruses, 11, 1995, pp. 160-160

Authors: ZON G
Citation: G. Zon, ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES - INTRODUCTORY CONCEPTS AND POSSIBLE MOLECULAR MECHANISMS OF TOXICITY, Toxicology letters, 82-3, 1995, pp. 419-424

Authors: MATSUKURA M KOIKE K ZON G
Citation: M. Matsukura et al., ANTISENSE PHOSPHOROTHIOATES AS ANTIVIRALS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) AND HEPATITIS-B VIRUS (HBV), Toxicology letters, 82-3, 1995, pp. 435-438

Authors: SKORSKI T NIEBOROWSKASKORSKA M CAMPBELL K IOZZO RV ZON G DARZYNKIEWICZ Z CALABRETTA B
Citation: T. Skorski et al., LEUKEMIA TREATMENT IN SEVERE COMBINED IMMUNODEFICIENCY MICE BY ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETING COOPERATING ONCOGENES, The Journal of experimental medicine, 182(6), 1995, pp. 1645-1653

Authors: MAEKAWA T KIMURA S HIRAKAWA K MURAKAMI A ZON G ABE T
Citation: T. Maekawa et al., SEQUENCE SPECIFICITY ON THE GROWTH SUPPRESSION AND INDUCTION OF APOPTOSIS OF CHRONIC MYELOID-LEUKEMIA CELLS BY BCR-ABL ANTISENSE OLIGODEOXYNUCLEOSIDE PHOSPHOROTHIOATES, International journal of cancer, 62(1), 1995, pp. 63-69

Authors: SKORSKI T NIEBOROWSKASKORSKA M SZCZYLIK C KANAKARAJ P PEROTTI D ZON G GEWIRTZ A PERUSSIA B CALABRETTA B
Citation: T. Skorski et al., C-RAF-1 SERINE THREONINE KINASE IS REQUIRED IN BCR ABL-DEPENDENT AND NORMAL HEMATOPOIESIS/, Cancer research, 55(11), 1995, pp. 2275-2278

Authors: SKORSKI T KANAKARAJ P NIEBOROWSKASKORSKA M RATAJCZAK MZ WEN SC ZON G GEWIRTZ AM PERUSSIA B CALABRETTA B
Citation: T. Skorski et al., PHOSPHATIDYLINOSITOL-3 KINASE-ACTIVITY IS REGULATED BY BCR ABL AND ISREQUIRED FOR THE GROWTH OF PHILADELPHIA-CHROMOSOME-POSITIVE CELLS/, Blood, 86(2), 1995, pp. 726-736

Authors: WILSON WD RATMEYER L CEGLA MT SPYCHALA J BOYKIN D DEMEUNYNCK M LHOMME J KRISHNAN G KENNEDY D VINAYAK R ZON G
Citation: Wd. Wilson et al., BULGED-BASE NUCLEIC-ACIDS AS POTENTIAL TARGETS FOR ANTIVIRAL DRUG-ACTION, New journal of chemistry, 18(3), 1994, pp. 419-423
Risultati: 1-25 | 26-50 | 51-58